Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers

Journal of Photochemistry and Photobiology B: Biology

Volumn 53, Issue 1-3, 1999, Pages 44-52

  Hammer Wilson, Marie J ^a   Akian, Lori ^a   Espinoza, Jenny ^a   Kimel, Sol ^a,b   Berns, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

5 Aminolevulinic acid (ALA); Benzoporphyrin derivative monoacid ring A (BPD MA); Lutetium texaphyrin (Lutex); Photodynamic therapy; Photofrin; Sulfonated chloro aluminum phthalocyanine (AlPcS(n)); Vascular damage

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; CHLOROALUMINUM PHTHALOCYANINE; LUTETIUM; LUTETIUM TEXAPHYRIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG UPTAKE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALIA;

EID: 0033380825     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(99)00124-4     Document Type: Article

References (63)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90:1998;889-905.
2. Schuitmaker J.J., Baas P., van Leengoed H.L.L.M., van der Meulen F.W., Star W.M., van Zandwijk N. Photodynamic therapy: a promising new modality for the treatment of cancer. J. Photochem. Photobiol. B: Biol. 34:1996;3-12.
3. Fisher A.M.R., Murphree A.L., Gomer C.J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17:1995;2-31.
4. Trauner K.B., Gandour-Edwards R., Bamberg M., Shortkroff S., Sledge C., Hasan T. Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem. Photobiol. 67:1998;133-139.
5. Asrani S., Zou S., D'Anna S., Lutty G., Vinores S.A., Goldberg M.F., Zeimer R. Feasibility of laser-targeted photoocclusion of the choriocapillary layer in rats. Invest. Ophthalmol. 38:1997;2702-2710.
6. Steiner R.A., Tadir Y., Tromberg B.J., Krasieva T., Gazains A.T., Wyss P., Berns M.W. Photosensitization of the rat endometrium following 5-aminolevulinic acid induced photodynamic therapy. Lasers Surg. Med. 18:1996;301-308.
7. Woodburn K.W., Fan Q., Kessel D., Wright M., Mody T.D., Hemmi G., Magda D., Sessler J.L., Dow W.C., Miller R.A., Young S.W. Phototherapy of cancer and atheromatous plaque with texaphyrins. J. Clin. Laser Med. Surg. 14:1996;343-348.
8. R. Hilf, Cellular targets of photodynamic therapy, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy. Basic Principles and Clinical Applications, Marcel Dekker, New York, 1992, pp. 47-54.
9. Star W.M., Marijnissen P.A., van den Berg-Blok A.E., Versteeg J.A.C., Franken K.A.P., Reinhold H.S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:1986;2532-2540.
10. Nelson J.S., Liaw L.H., Orenstein A., Roberts W.G., Berns M.W. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl. Cancer Inst. 80:1988;1599-1605.
11. D. Kessel, C.J. Byrne, A.D. Ward, Photosensitizing dyes related to hematoporphyrin derivative: structure-activity relationships, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy. Basic Principles and Clinical Applications, Marcel Dekker, New York, 1992, pp. 129-143.
12. Boyle R.W., Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64:1996;469-485.
13. Jori G. Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol. B: Biol. 36:1996;87-93.
14. B. Paquette, J.E. van Lier, Phthalocyanines and related compounds: structure-activity relationships, in: B.W. Henderson, T.J. Dougherty (Eds.), Photodynamic Therapy. Basic Principles and Clinical Applications, Marcel Dekker, New York, 1992, pp. 145-156.
15. Allison B.A., Waterfield E., Richter A.M., Levy J.G. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem. Photobiol. 54:1991;709-715.
16. Richter A.M., Waterfield E., Jain A.K., Canaan A.J., Allison B.A., Levy J.G. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol. 57:1993;1000-1006.
17. Young S.W., Woodburn K.W., Wright M., Mody T.D., Fan Q., Sessler J.L., Dow W.C., Miller R.A. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem. Photobiol. 63:1996;892-897.
18. Woodburn K.W., Fan Q., Miles D.R., Kessel D., Luo Y., Young S.W. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem. Photobiol. 65:1997;410-415.
19. Woodburn K.W., Fan Q., Kessel D., Luo Y., Young S.W. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J. Invest. Dermatol. 110:1998;746-751.
20. Kennedy J.C., Pottier R.H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol. 14:1992;275-292.
21. Evensen J.F., Moan J. A test of different photosensitizers for photodynamic treatment of cancer in a murine tumor model. Photochem. Photobiol. 46:1987;859-865.
22. Moan J., Peng Q., Evensen J.F., Berg K., Western A., Rimington C. Photosensitizing efficiencies, tumor- and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem. Photobiol. 46:1987;713-721.
23. Peng Q., Moan J. Correlation of distribution of sulphonated phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Br. J. Cancer. 72:1995;565-574.
24. Zaidi S.A.A., Oleinick N.L., Zaim M.T., Mukhtar H. Apoptosis during photodynamic therapy-induced ablation of RIF-1 tumors in C3H mice: electron microscopic, histopathologic and biochemical evidence. Photochem. Photobiol. 58:1993;771-776.
25. Koshida K., Hisazumi H., Komatsu K., Hirata A., Uchibayashi T. Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy. Urol. Res. 21:1993;283-288.
26. J.S. Nelson, W.G. Roberts, L.H. Liaw, M.W. Berns, Cellular and tumor model studies using several PDT sensitizers, in: D. Kessel (Ed.), Photodynamic Therapy of Neoplastic Disease, vol. 1, CRC Press, Boca Raton, FL, 1990, pp. 147-168.
27. Stern S.J., Flock S., Small S., Thomsen S., Jacques S. Chloroaluminum sulfonated phthalocyanine versus dihematoporphyrin ether: early vascular events in the rat window chamber. Laryngoscope. 101:1991;1219-1225.
28. Barr H., MacRobert A.J., Tralau C.J., Boulos P.B., Bown S.G. The significance of the nature of the photosensitiser for photodynamic therapy: quantitative and biological studies in the colon. Br. J. Cancer. 62:1990;730-735.
29. Farrell T.J., Wilson B.C., Patterson M.S., Olivo M.C. Comparison of the in vivo photodynamic threshold dose for Photofrin, mono- and tetrasulfonated aluminum phthalocyanine using a rat liver model. Photochem. Photobiol. 68:1998;394-399.
30. Hemming A.W., Davis N.L., Dubois B., Quenville N.F., Finley R.J. Photodynamic therapy of squamous cell carcinoma. An evaluation of a new photosensitizing agent, benzoporphyrin derivative and new photoimmunoconjugate. Surg. Oncol. 2:1993;187-196.
31. Korbelik M., Krosl G. Cellular levels of photosensitizers in tumours: the role of proximity to the blood supply. Br. J. Cancer. 70:1994;604-610.
32. Kostenich G., Orenstein A., Roitman L., Malik Z., Ehrenberg B. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high fluence rate pulsed light delivery system. J. Photochem. Photobiol. B: Biol. 39:1997;36-42.
33. G. Kostenich, A. Orenstein, Z. Malik, B. Ehrenberg, Preclinical photodynamic therapy studies with endogenous and new exogenous photosensitizers, in: J.G. Moser (Ed.), Photodynamic Tumor Therapy, Harwood, Amsterdam, 1998, pp. 101-114.
34. Hammer-Wilson M.J., Ghahramanlou M., Berns M.W. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system. Lasers Surg. Med. 24:1999;276-284.
35. Cairnduff F., Roberts D.J.H., Dixon B., Brown S.B. Response of a rodent fibrosarcoma to photodynamic therapy using 5-aminolaevulinic acid (ALA) or polyhaematoporphyrin. Int. J. Radiat. Biol. 67:1995;93-99.
36. Orenstein A., Kostenich G., Roitman L., Shechtman Y., Kopolovic Y., Ehrenberg B., Malik Z. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II, and ALA-induced protoporphyrin XI in a colon carcinoma model. Br. J. Cancer. 73:1996;937-944.
37. Chang C.J., Sun C.H., Liaw L.H.L., Berns M.W., Nelson J.S. In vitro and in vivo photosensitizing capabilities of 5-ALA versus Photofrin in vascular endothelial cells. Lasers Surg. Med. 24:1999;178-186.
38. Mlkvy P., Messmann H., Regula J., Conio M., Pauer M., Millson C.E., MacRobert A.J., Bown S.G. Photodynamic therapy for gastrointestinal tumors using three photosensitizers - ALA induced PPIX, Photofrin and MTHPC. A pilot study. Neoplasma. 45:1998;157-161.
39. Hillemanns P., Korell M., Schmitt-Sody M., Baumgartner R., Beyer W., Kimmig R., Untch M., Hepp H. Photodynamic therapy in women with cervical intraepithelial neoplasia using topically applied 5-aminolevulinic acid. Int. J. Cancer. 81:1999;34-38.
40. Chang S.C., Buonaccorsi G., MacRobert A.J., Bown S.G. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration. Lasers Surg. Med. 20:1997;252-264.
41. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.E., Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer. 79:1997;2282-2308.
42. Orenstein A., Kostenich G., Malik Z. The kinetics of protoporphyrin fluorescence during ALA-PDT in human malignant skin tumors. Cancer Lett. 120:1997;229-234.
43. DeFouw D.O., Rizzo V.J., Steinfeld R., Feinberg R.N. Mapping of the microcirculation in the chick chorioallantoic membrane during normal angiogenesis. Microvasc. Res. 38:1989;333-336.
44. Fuchs A., Lindenbaum E.S. The two- and three-dimensional structure of the microcirculation of the chick chorioallantoic membrane. Acta Anat. 131:1988;271-275.
45. Gottfried V., Lindenbaum E.S., Kimel S. Vascular damage during PDT as monitored in the chick chorioallantoic membrane. Int. J. Radiat. Biol. 60:1991;349-354.
46. Gottfried V., Davidi R., Averbuj C., Kimel S. In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy. J. Photochem. Photobiol. B: Biol. 30:1995;115-121.
47. Kimel S., Svaasand L.O., Hammer-Wilson M., Gottfried V., Cheng S., Svaasand E., Berns M.W. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model. Lasers Surg. Med. 12:1992;432-440.
48. Kimel S., Svaasand L.O., Hammer-Wilson M., Schell M.J., Milner T.E., Nelson J.S., Berns M.W. Differential vascular response to laser photothermolysis. J. Invest. Dermatol. 103:1994;693-700.
49. Fritsch C., Batz J., Bolsen K., Ruzicka T., Goerz G. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch. Dermatol Res. 288:1996;517-521.
50. Loh C.S., Vernon D., MacRobert A.J., Bedwell J., Bown S.G., Brown S.B. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol. B:Biol. 20:1993;47-54.
51. Henderson B.W., Vaughan L., Bellnier D.A., van Leengoed H., Johnson P.G., Oseroff A.R. Photosensitization of murine tumor, vasculature, and skin by using 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol. 62:1995;780-789.
52. Peng Q., Moan J., Kongshaug M., Evensen J.F., Anholt H., Rimington C. Sensitizer for photodynamic therapy of cancer: a comparison of the tissue distribution of Photofrin I and aluminum phthalocyanine tetrasulfonate in nude mice bearing a human malignant tumor. Int. J. Cancer. 48:1991;258-264.
53. Sorensen R., Iani V., Moan J. Kinetics of photobleaching of protoporphyrin IX in the skin of nude mice exposed to different fluence rates of red light. Photochem. Photobiol. 68:1998;835-840.
54. Sitnik T.M., Hampton J.A., Henderson B.W. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br. J. Cancer. 77:1998;1386-1394.
55. Sitnik T.M., Henderson B.W. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem. Photobiol. 67:1998;462-466.
56. Uehara M., Inokuchi T., Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J. Oral Maxillofac. Surg. 54:1996;729-736.
57. Fingar V.H., Wieman T.J., Wiehle S.A., Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 52:1992;4914-4921.
58. Hornung R., Hammer-Wilson M.J., Kimel S., Liaw L.H., Tadir Y., Berns M.W. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: Photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors. J. Photochem. Photobiol. B: Biol. 49:1999;41-49.
59. A.L. Romanoff, A.J. Romanoff, Biochemistry of the Avian Embryo: a Quantitative Analysis of Prenatal Development, Interscience Publishers, New York, 1967, p. 341.
60. Reed M.W., Wieman T.J., Schuschke D.A., Miller F.N. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res. 119:1989;542-552.
61. Gibson L., Havens J.J., Foster T.H., Hilf R. Time-dependent intracellular accumulation of delta-aminolevulinic acid, induction of porphyrin synthesis and subsequent phototoxicity. Photochem. Photobiol. 65:1997;416-421.
62. 2, in: D. Kessel (Ed), Photodynamic Therapy of Neoplastic Disease, vol. 2, CRC Press, Boca Raton, FL, 1990, pp. 29-42.
63. Liu D.L., Andersson-Engels S., Sturesson C., Svanberg K., Hakansson C.H., Svanberg S. Tumor vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy. Cancer Lett. 111:1997;157-165.